BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Sook Jin Lee, Kyung Hee Kim, Suk Keun Hong, Shelley Hankins. Evaluation of a Heart Transplant CandidateCurrent Cardiology Reports 2017; 19(12) doi: 10.1007/s11886-017-0934-y
2
Paul Carrier, Marie Essig, Marilyne Debette-Gratien, Denis Sautereau, Annick Rousseau, Pierre Marquet, Jérémie Jacques, Véronique Loustaud-Ratti. Anti-hepatitis C virus drugs and kidneyWorld Journal of Hepatology 2016; 8(32): 1343-1353 doi: 10.4254/wjh.v8.i32.1343
3
Experimental and Clinical Transplantation 2017; 15(1) doi: 10.6002/ect.2015.0341
4
Hideki Ohdan. Should organs from hepatitis C virus-infected donors be used for transplantation in the era of DAAs?Transplant International 2017; 30(9): 860 doi: 10.1111/tri.12971
5
Wolfgang Poller, Arash Haghikia, Mario Kasner, Ziya Kaya, Udo Bavendiek, Heiner Wedemeier, Hans-Jörg Epple, Carsten Skurk, Ulf Landmesser. Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral TherapiesJournal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00057
6
Experimental and Clinical Transplantation 2018;  doi: 10.6002/ect.2017.0332
7
K. E. Doucette, K. Halloran, A. Kapasi, D. Lien, J. G. Weinkauf. Outcomes of Lung Transplantation in Recipients With Hepatitis C Virus InfectionAmerican Journal of Transplantation 2016; 16(8): 2445 doi: 10.1111/ajt.13796
8
Parmvir Parmar, Curtis Cooper. Management of hepatitis C in a patient undergoing solid organ (kidney) transplantOfficial Journal of the Association of Medical Microbiology and Infectious Disease Canada 2018; 3(4): 231 doi: 10.3138/jammi.2017-0009
9
Maria Stepanova, Trevor Locklear, Nila Rafiq, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi. Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registryClinical Transplantation 2016; 30(12): 1570 doi: 10.1111/ctr.12859
10
Chen-Hua Liu, Yih-Sharng Chen, Sheoi-Shen Wang, Chun-Jen Liu, Tung-Hung Su, Hung-Chih Yang, Chun-Ming Hong, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao. Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus InfectionClinical Infectious Diseases 2018; 66(2): 289 doi: 10.1093/cid/cix787
11
Ayman Yosry, Hadeel Gamal Eldeen, Eman Medhat, Mai Mehrez, Naglaa Zayed, Wafaa Elakel, Reham Abdelmoniem, Mona Kaddah, Ashraf Abdelaziz, Gamal Esmat, Magdy EL‐Serafy, Wahid Doss. Efficacy and safety of sofosbuvir‐based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experienceJournal of Medical Virology 2018;  doi: 10.1002/jmv.25362
12
Nicole Theodoropoulos, Bryan A. Whitson, Stanley I. Martin, Stephanie Pouch, Amy Pope-Harman. Successful treatment of donor-derived hepatitis C infection in a lung transplant recipientTransplant Infectious Disease 2017; 19(2): e12659 doi: 10.1111/tid.12659
13
Mário J. Silva, Cláudia Pereira, Rafaela Loureiro, Catarina Balsa, Paulo Lopes, Ivone Água-Doce, Elsa Belo, Helena C. Martins, Rodrigo Coutinho, Elizabeth Pádua. Hepatitis C in a Mobile Low-Threshold Methadone ProgramEuropean Journal of Gastroenterology & Hepatology 2017; 29(6): 657 doi: 10.1097/MEG.0000000000000843
14
Denise J. Lo, Blayne A. Sayed, Nicole A. Turgeon. Pancreas transplantation in unconventional recipientsCurrent Opinion in Organ Transplantation 2016; 21(4): 393 doi: 10.1097/MOT.0000000000000334
15
Megan K. Morales, Matthew Cooper, Peter Abrams, Joseph G. Timpone. Principles and Practice of Transplant Infectious Diseases2019; : 73 doi: 10.1007/978-1-4939-9034-4_4
16
A.E. Shafii, D.D. Harris, M. Baz. Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case ReportTransplantation Proceedings 2017; 49(7): 1682 doi: 10.1016/j.transproceed.2017.06.002
17
Martina Vitrone, Roberto Andini, Irene Mattucci, Ciro Maiello, Luigi Atripaldi, Emanuele Durante-Mangoni, Rosa Zampino. Direct antiviral treatment of chronic hepatitis C in heart transplant recipientsTransplant Infectious Disease 2018; 20(1): e12813 doi: 10.1111/tid.12813
18
Wolfgang Poller, Ziya Kaya, Marion Muche, Mario Kasner, Carsten Skurk, Kai Kappert, Rudolf Tauber, Felicitas Escher, Heinz-Peter Schultheiss, Hans-Jörg Epple, Ulf Landmesser. High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infectionClinical Research in Cardiology 2017; 106(7): 551 doi: 10.1007/s00392-017-1086-1
19
Diğdem Özer Etik, Nuretdin Suna, Serkan Öcal, Haldun Selçuk, Ülkü Dağlı, Turan Çolak, Fatih Hilmioğlu, Ahmet Sedat Boyacıoğlu, Mehmet Haberal. Successful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant RecipientsExperimental and Clinical Transplantation 2019; 17(1): 52 doi: 10.6002/ect.2018.0095
20
Núria Esforzado, José María Morales. Hepatitis C y trasplante renal: el tiempo de la erradicación del virus ha llegadoNefrología 2019;  doi: 10.1016/j.nefro.2019.01.002
21
Wisit Cheungpasitporn, Charat Thongprayoon, Karn Wijarnpreecha, Ankit Sakhuja, Wonngarm Kittanamongkolchai, Jackrapong Bruminhent. Efficacy and safety of direct-acting antivirals for treatment of hepatitis C infected kidney transplant recipients; a meta-analysisJournal of Nephropharmacology 2017; 6(2): 49 doi: 10.15171/npj.2017.04
22
B. Khan, L. G. Singer, L. B. Lilly, C. Chaparro, T. Martinu, S. Juvet, M. Pipkin, T. K. Waddell, S. Keshavjee, A. Humar, M. Cypel. Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative RecipientAmerican Journal of Transplantation 2017; 17(4): 1129 doi: 10.1111/ajt.14137